CapsoVision CV
NASDAQ CV
$5.95 -0.17 (-2.78%)
At close: Aug 20, 2026 · 2:54 PM UTC

CapsoVision (CV) Other Operating Expenses (2024 - 2026)

CapsoVision (CV) posted Other Operating Expenses of $5.3 million for Q4 2025, down 13.46% sequentially from $6.1 million in Q3 2025, and up 69.13% YoY from $3.1 million in Q4 2024.

CapsoVision (CV) Other Operating Expenses (2024 - 2026) Analysis & Trends

CapsoVision has reported Other Operating Expenses for 2 years, with the latest figure at $5.3 million in Q4 2025.

  • Quarterly Other Operating Expenses rose 69.13% year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.3 million (changed N/A YoY) and the FY2025 annual result came in at $18.3 million, up 21.1% from the prior year.
  • Other Operating Expenses retreated to $5.3 million in Q4 2025 per CV's latest filing, from $6.1 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $6.1 million in Q3 2025 and troughed at $1.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.75 Bn 194.14 Bn 7.27 Bn
2 Stryker 127.36 Bn 123.88 Bn 4.50 Bn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn
4 Boston Scientific 73.20 Bn 72.66 Bn 3.85 Bn
5 Edwards Lifesciences 52.10 Bn 47.85 Bn 1.35 Bn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn
7 GE HealthCare Technologies 33.77 Bn 31.66 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn
10 CapsoVision 297.13 Mn 288.05 Mn 1.87 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.94 Mn
Dec 31, 2025 5.27 Mn
Sep 30, 2025 6.09 Mn
Jun 30, 2025 1.85 Mn
Dec 31, 2024 3.12 Mn
Sep 30, 2024 4.52 Mn
Jun 30, 2024 4.22 Mn